tirzepatide compound no longer available FDA ban on compounded tirzepatide: Switch to name brand medications Compounded Tirzepatide Weight Loss Program

Food and Drug Administration (FDA) released the following Class I recall information in its January 9, 2002 Enforcement Report

A licensed provider trained in weight management will review your answers and determine if youre a good candidate for medication

Residential care communities Fortytwo percent of individuals in residential care communities (i.e., housing that includes services to assist with everyday activities, such as personal care, medication management and meals), including assisted living communities, had Alzheimer's or other dementias in 2020, up from 34% in 2016

However, like any medication, these drugs also come with risks that are still being realized and understood